ChiCTR2100045496 版本V1.1 版本创建时间2021/11/19 22:08:14 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2100045496 

最近更新日期:

Date of Last Refreshed on:

2021-11-19 22:00:28 

注册时间:

Date of Registration:

2021-04-17 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

请于伦理委员会批准后才开始征募参试者,并与我们联系上传伦理批件。 针刺对湿热质单纯性肥胖人群临床疗效及脂代谢的影响

Public title:

Effect of Acupuncture on Clinical Efficacy and Lipid Metabolism of Simple Obesity Patients with Damp-heat Constitution

注册题目简写:

English Acronym:

研究课题的正式科学名称:

针刺对湿热质单纯性肥胖人群临床疗效及脂代谢的影响

Scientific title:

Effect of Acupuncture on Clinical Efficacy and Lipid Metabolism of Simple Obesity Patients with Damp-heat Constitution

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiMCTR2100004744

申请注册联系人:

张昕 

研究负责人:

谭奇纹 

Applicant:

Zhang Xin 

Study leader:

Tan Qiwen 

申请注册联系人电话:

Applicant telephone:

+86 13953172234

研究负责人电话:

Study leader's
telephone:

+86 13793188118

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

doctorzhangxin@163.com

研究负责人电子邮件:

Study leader's E-mail:

doctorzhangxin@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

山东省济南市历下区经十路16369号

研究负责人通讯地址:

山东省济南市历下区经十路16369号

Applicant address:

16369 Jingshi Road, Lixia District, Ji'nan, Shandong, China

Study leader's address:

16369 Jingshi Road, Lixia District, Ji'nan, Shandong, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

山东中医药大学

Applicant's institution:

Shandong University of Traditional Chinese Medicine

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

(2021)伦审第(018)号--KY

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

山东中医药大学附属医院伦理委员会

Name of the ethic committee:

Ethics Committee of Attached Hospital of Shandong University of TCM

伦理委员会批准日期:

Date of approved by ethic committee:

1990-01-01 00:00:00

伦理委员会联系人:

张鑫

Contact Name of the ethic committee:

Xin Zhang

伦理委员会联系地址:

山东省济南市历下区经十路16369号

Contact Address of the ethic committee:

16369 Jingshi Road, Lixia District, Ji'nan, Shandong, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

山东中医药大学附属医院治未病中心

Primary sponsor:

Affiliated Hospital of Shandong University of Traditional Chinese Medicine

研究实施负责(组长)单位地址:

山东省济南市历下区经十路16369号

Primary sponsor's address:

16369 Jingshi Road, Lixia District, Ji'nan, Shandong, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

山东

市(区县):

济南

Country:

China

Province:

Shandong

City:

Ji'nan

单位(医院):

山东中医药大学附属医院

具体地址:

历下区经十路16369号

Institution
hospital:

The Affiliated Hospital of Shandong University of Traditional Chinese Medicine

Address:

16369 Jingshi Road, Lixia District

经费或物资来源:

山东中医药大学治未病科研创新团队

Source(s) of funding:

The scientific research and innovation team of ZhiWeiBing of Shandong University of Traditional Chinese Medicine

研究疾病:

单纯性肥胖  

Target disease:

Simple obesity

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

本课题通过对湿热质单纯性肥胖人群进行针刺治疗,观察针刺对湿热质单纯性肥胖人群体重等相关指标的改善作用,并观察针刺对其脂代谢的影响,为针刺治疗湿热质肥胖及改善脂代谢提供客观依据。  

Objectives of Study:

In this study, acupuncture was used to treat simple obesity with damp-heat constitution, to observe the effect of acupuncture on body weight and other related indexes of simple obesity with damp-heat constitution, and to observe the effect of acupuncture on lipid metabolism, to provide objective basis for acupuncture treatment of damp-heat obesity and improvement of lipid metabolism.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.符合且28kg/m2≤体重指数(BMI)<32kg/m2的单纯性肥胖患者,并符合湿热质中医诊断标准。
2.年龄在18~60周岁之间,性别不限。
3.近2个月内未使用减肥药以及其他减肥方法者。
4.自愿参加并且能够配合临床指标检测,签署知情同意书。

Inclusion criteria

1. The patients with simple obesity met the diagnostic criteria of Western medicine that 28kg/m2≤BMI<32kg/m2 , and met the traditional Chinese medicine diagnostic criteria of damp-heat constitution.
2. Between the ages of 18 and 60, regardless of gender.
3. No use of diet pills and other methods of losing weight in the past 2 months.
4. Voluntary participation and ability to cooperate with clinical indicators test, sign informed consent.

排除标准:

1.继发性肥胖患者,如下丘脑综合症、性腺功能不全、甲状腺功能减退症、库欣综合征、多囊卵巢综合征、肿瘤、药物等原因导致的肥胖。
2.合并有严重心脑血管疾患、肝肾功能不全、血液系统疾病等严重原发性疾病。
3.患有严重的精神类疾病。
4.严重过敏体质,或近期有感染史者。
5.皮肤溃疡者。
6.正在进行或近2个月进行了其他减肥治疗者。

Exclusion criteria:

1. Secondary obesity, such as hypothalamic syndrome, gonadal dysfunction, hypothyroidism, Cushings syndrome, polycystic ovary syndrome, tumors, drugs and other causes of obesity.
2. It was complicated with heart, brain and blood vessel disease, liver and kidney dysfunction, blood system disease and other serious primary diseases.
3. Suffering from severe mental illness.
4.People with severe allergies or a recent history of infection.
5. People with skin ulcers.
6. Those who are undergoing or have been undergoing other weight loss treatments for nearly 2 months.

研究实施时间:

Study execute time:

From 2021-04-20 00:00:00 To 2022-03-16 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-04-20 00:00:00 To 2022-03-16 00:00:00

干预措施:

Interventions:

组别:

试验组

样本量:

36

Group:

experimental group

Sample size:

干预措施:

针刺配合生活方式干预

干预措施代码:

Intervention:

Acupuncture combined with lifestyle intervention

Intervention code:

组别:

对照组

样本量:

36

Group:

control group

Sample size:

干预措施:

生活方式干预

干预措施代码:

Intervention:

Lifestyle intervention

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

山东 

市(区县):

济南 

Country:

China

Province:

Shandong

City:

Jinan

单位(医院):

山东中医药大学附属医院 

单位级别:

三级甲等 

Institution
hospital:

The Attached Hospital of Shandong University of TCM

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

体重

指标类型:

主要指标

Outcome:

Weight

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

体重指数

指标类型:

主要指标

Outcome:

BMI

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

脂肪百分率

指标类型:

主要指标

Outcome:

Fat percentage

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

腰围

指标类型:

主要指标

Outcome:

Waist circumference

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

臀围

指标类型:

主要指标

Outcome:

Hip circumference

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

腰臀比

指标类型:

主要指标

Outcome:

Waist to hip ratio

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

皮下脂肪厚度

指标类型:

主要指标

Outcome:

Subcutaneous fat thickness

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血压

指标类型:

主要指标

Outcome:

Blood pressure

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

体质评分

指标类型:

次要指标

Outcome:

Physique score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

体重对生活冲击量表

指标类型:

次要指标

Outcome:

Weight impact on life scale(IWQOL-Lite)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

生存质量量表

指标类型:

次要指标

Outcome:

Quality of life scale(SF-36)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

综合医院焦虑/抑郁情绪测定表

指标类型:

次要指标

Outcome:

General Hospital Anxiety/Depression Mood Scale(HAD)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

自尊量表

指标类型:

次要指标

Outcome:

Self-esteem scale

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

甘油三酯

指标类型:

主要指标

Outcome:

Triglycerides

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

总胆固醇

指标类型:

主要指标

Outcome:

Total cholesterol

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

低密度脂蛋白胆固醇

指标类型:

主要指标

Outcome:

Low Density Lipoprotein Cholesterol

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

高密度脂蛋白胆固醇

指标类型:

主要指标

Outcome:

HDL Cholesterol

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

游离脂肪酸

指标类型:

主要指标

Outcome:

Free fatty acid

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

载脂蛋白A1

指标类型:

主要指标

Outcome:

Apolipoprotein A1

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

载脂蛋白B

指标类型:

主要指标

Outcome:

Apolipoprotein B

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

脂蛋白α

指标类型:

主要指标

Outcome:

lipoprotein α

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 59 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

随机数字表法

Randomization Procedure (please state who generates the random number sequence and by what method):

Random digital table method

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

共享网盘

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Shared network disk

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据采集和数据核实管理由不同的专人负责。数据采集记录CRF表格,数据管理由山东中医药大学治未病科研创新团队储存。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data collection and data verification management are handled by different individuals. The data collection records the CRF form and the data management is stored by the scientific research and innovation team of ZhiWeiBing of Shandong University of TCM.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2021-04-17 04:11:30